Our analysis not only confirmed the hepcidin downregulation in malignant liver tissues compared to benign tissues, but also found a strong association between hepcidin downregulation and liver cancer risk factors, cancer grade, tumor stage, and patient survival. This evidence concerns the gene HAMP and liver cancer.